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Abstract
Introduction: Weaning protocols that include noninvasive ventilation (NIV) decrease re-intubation rates and ICU
length of stay. However, impaired airway clearance is associated with NIV failure. Mechanical insufflation-exsufflation
(MI-E) has been proven to be very effective in patients receiving NIV. We aimed to assess the efficacy of MI-E as
part of an extubation protocol.
Method: Patients with mechanical ventilation (MV) for more than 48 hours with specific inclusion criteria, who
successfully tolerated a spontaneous breathing trial (SBT), were randomly allocated before extubation, either for (A)
a conventional extubation protocol (control group), or (B) the MI-E extubation protocol (study group). During the
postextubation period (48 hours), group A patients received standard medical treatment (SMT), including NIV in
case of specific indications, whereas group B received the same postextubation approach plus three daily sessions
of mechanical in-exsufflation (MI-E). Reintubation rates, ICU length of stay, and NIV failure rates were analyzed.
Results: Seventy-five patients (26 women) with a mean age of 61.8 ± 17.3 years were randomized to a control
group (n = 40; mean SAPS II, 47.8 ± 17.7) and to a study group (n = 35; mean SAPS II, 45.0 ± 15.0). MV time before
enrollment was 9.4 ± 4.8 and 10.5 ± 4.1 days for the control and the study group, respectively. In the 48 hours
after extubation, 20 control patients (50%) and 14 study patients (40%) used NIV. Study group patients had a
significant lower reintubation rate than did controls; six patients (17%) versus 19 patients (48%), P < 0.05;
respectively, and a significantly lower time under MV; 17.8 ± 6.4 versus 11.7 ± 3.5 days; P < 0.05; respectively.
Considering only the subgroup of patients that used NIV, the reintubation rates related to NIV failure were
significantly lower in the study group when compared with controls; two patients (6%) versus 13 (33%); P < 0.05,
respectively. Mean ICU length of stay after extubation was significantly lower in the study group when compared
with controls (3.1 ± 2.5 versus 9.8 ± 6.7 days; P < 0.05). No differences were found in the total ICU length of stay.
Conclusion: Inclusion of MI-E may reduce reintubation rates with consequent reduction in postextubation ICU
length of stay. This technique seems to be efficient in improving the efficacy of NIV in this patient population.
Introduction
The process of weaning from mechanical ventilation
must balance the risk of complications due to unneces-
sary delays in extubation with the risk of complications
due to early discontinuation and the need for reintuba-
tion [1]. Patients who require reintubation have been
noted to have a significantly higher mortality rate than
those who are successfully extubated on the first
attempt [2].
Patients in the intensive care setting very often have
impaired airway clearance. Endotracheal intubation pre-
vents the patient from closing the glottis, which is
necessary for effective coughing [3]. Care of the intu-
bated patient includes direct suction applied through
the endotracheal tube which clears a small portion of
the airway, is ineffective for clearing secretions in the
peripheral airways, and leaves the patient dependent on
mucociliary clearance rather than on cough clearance
[4]. Deep insufflation with a self-inflating ventilation bag
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can help, especially if accompanied by chest physiother-
apy, but it does not recreate a cough [5].
Ventilator-associated pneumonia is an exceedingly
common problem in intensive care units (ICUs), occur-
ring in as many as 27% of patients [6]. The reasons for
this are complex, but a significant role is played by the
aspiration of upper-airway secretions and gastric con-
tents [7]. Despite the many reports and reviews on ven-
tilator-associated pneumonia, little emphasis is placed
on airway clearance [8].
Predictors for successful weaning include respiratory
rate less than 38 per minute and a rapid shallow breath-
ing index below 100 breaths/min/L [9]. However, even
in patients who satisfy weaning criteria and pass ventila-
tor-weaning trials, an extubation failure rate of 10% to
20% exists [10].
Postextubation respiratory failure is defined as the
presence of signs and symptoms of respiratory distress
in the first 48 hours after extubation. The reasons given
for extubation failure include lack of improvement in
the work of breathing, hypoxemia, respiratory acidosis,
retained secretions, and decreased consciousness [11].
However, if at extubation, the lungs are healthy and
ventilation can be fully maintained noninvasively [12],
then the only remaining concern is the effective expul-
sion of airway secretions [13]. Despite the importance of
this factor, no ventilator weaning parameter addresses
the ability to cough.
Early extubation, coupled with the use of noninvasive
ventilatory support, has been used effectively to facilitate
weaning [14,15], improve survival [16], decrease the
incidence of ventilator-associated pneumonia [17,18],
and reduce ICU length of stay [16,18]. However, a
higher risk of NIV failure is seen when this is applied in
patients that develop acute respiratory failure (ARF)
after extubation, and the evidence that supports its
application is controversial [19-21].
Despite a great interest in this field, the role of
impaired airway-secretion clearance on the outcome of
postextubation respiratory failure in critically ill ventila-
tor-dependent patients is still not clear. Airway clear-
ance may be impaired in disorders associated with
abnormal cough mechanics, altered mucus rheology,
altered mucociliary clearance, or structural airway
defects. In recent years, new technologies and more
advanced techniques have been developed to be more
effective in secretion clearance for patients with acute
respiratory failure [22-24].
Mechanical insufflation-exsufflation (MI-E) has been
described as an efficient technique in patients with
chronic muscle weakness [25-27]. It applies positive
pressure followed by negative pressure across the entire
airway (both central and peripheral), in contrast to
direct tracheal suction, which applies negative pressure
to a small, localized area [28]. This therapy is perhaps
the most physiologic mechanical recreation of a natural
cough, and we hypothesized that when applied after
extubation, it may improve secretion clearance in critical
ill respiratory patients and have positive outcomes on
their postextubation condition.
The purpose of this study was to assess the efficacy of
MI-E in preventing reintubation for patients in whom
acute respiratory failure develops after extubation.
Materials and methods
The data of this randomized control trial were gathered
in a 12-bed general ICU between 2007 and 2009. The
study was approved by the ethical committee of the São
João University Hospital and institutional review board,
and all the necessary participation consents were given.
Patients
Patients older than 18 years and under mechanical ven-
tilation for more than 48 hours, for acute hypoxemic
and/or hypercapnic respiratory failure from a specific
etiology, were evaluated for discontinuation of mechani-
cal ventilation through the application of a spontaneous
breathing trial (SBT).
The application of an SBT trial was considered appro-
priate when all of the following criteria were met:
improvement of the condition that caused acute respira-
tory failure, respiratory rate less than 38 per minute,
rapid shallow breathing index below 100 breaths/min/L
[9], suspension of sedative medications, ability to stay
alert and communicate, core temperature less than 38°C
throughout the last 24 hours, suspension of vasoactive
drugs, with the exception of dopamine at doses lower
than 5 μg per kilogram of body weight per minute, and
partial pressure of oxygen greater than 60 mm Hg on
an inspired fraction of oxygen (FiO2) of 0.40 (PaO2/FiO2
>200) or less, with a positive end-expiratory pressure
(PEEP) of 5 cm H2O.
Discontinuation of mechanical ventilation was
assessed with a trial of spontaneous breathing with a T-
tube on a FiO2 of 50% for up to 60 to 120 minutes. The
SBT was considered successful when, during the trial
time, none of the following symptoms were found:
respiratory rate, > 35 beats/min; SpO2 < 90%; 20% varia-
tion of heart rate or blood pressure, respiratory distress,
agitation, and loss of consciousness [29].
Patients who successfully tolerated one SBT were ran-
domly allocated before extubation, by using a computer-
generated table either for (A) conventional extubation
protocol (control group) or (B) MI-E extubation proto-
col (study group). The randomization table and alloca-
tion sequence were concealed both from the primary
investigator and from all medical, respiratory therapy,
and nursing staff of the ICU. After each allocation, the
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primary investigator informed the staff of the group in
which the patient was included.
During the first 48 hours after extubation, patients
were observed for symptoms of acute respiratory dis-
tress/insufficiency as defined by dyspnea and the pre-
sence of at least two of the following: respiratory
acidosis (pH < 7.35 with a PaCO2 >45 mm Hg),
increased use of accessory respiratory muscles, increased
respiratory rate (> 35 beats/min), and decreasing oxyhe-
moglobin saturation (that is, SpO2 < 90% and PaO2 <
80 mm Hg, with FiO2 > 50%.
Group A patients received (postextubation) standard
medical treatment (SMT), including NIV in case of spe-
cific indications, whereas Group B received the same
postextubation approach plus mechanical in-exsufflation
(MI-E).
Patients with persistent weaning failure who failed
three or more SBTs in 1 week were excluded. Exclusion
criteria also included facial or cranial trauma, tracheost-
omy, active upper gastrointestinal bleeding, neurologic
instability (inability to respond to direct simple orders),
hemodynamic instability, lack of cooperation, and con-
firmed diagnosis of neuromuscular disease.
Standard medical therapy
All patients received postextubation standard medical
therapy, including supplemental oxygen, as needed,
respiratory chest physiotherapy, bronchodilators, anti-
biotics, and any other therapies, as directed by the
attending physician.
Criteria for NIV were the same in the two groups in
the first 48 hours after extubation. Patients were sub-
mitted to NIV, if they met at least one of the following
criteria, as judged after they had undergone the assigned
treatment: respiratory rate, > 35 beats/min; SpO2, <
90%; 20% variation of heart rate or blood pressure; dys-
pnea with respiratory distress; PaO2 < 60 mm Hg;
PaCO2 > 45 mm Hg; pH < 7.35. The failure of NIV was
declared when the main criteria for its application were
not solved or the patient showed intolerance to the
technique in the first 2 hours of use.
Noninvasive ventilation was provided via an ICU ven-
tilator with noninvasive mode or via a portable pres-
sure-cycled ventilator through an oronasal mask as the
first choice. Other interfaces, such as nasal, total face,
helmet, and mouthpieces were used in case of patient’s
intolerance to the oronasal mask.
The fraction of inspired oxygen and the positive end-
expiratory pressure were titrated to maintain the arterial
oxygen saturation above 90% (or PaO2 > 60 mm Hg).
The ventilator settings were subsequently adjusted as
needed for the patient’s comfort. The facial skin was
assessed every 4 hours to prevent damage from the
tightly fitting mask.
The decision regarding when to discontinue noninva-
sive ventilation was left to the attending physician.
Mechanical insufflation-exsufflation protocol (study
group)
After passing the SBT and being randomized to the
study group, before extubation, all patients were sub-
mitted to a treatment of MI-E (three sessions) with the
Cough Assist (Philips Respironics, Carlsbad, CA, USA)
through the endotracheal tube with pressures set at 40
cm H2O for insufflation and -40 cm H2O for exsuffla-
tion pressure. An insufflation/exsufflation time ratio of
3:2 seconds and a pause of 3 seconds between each
cycle were used. Eight cycles were applied in every ses-
sion with an abdominal thrust timed to the exsufflation
cycle.
In addition to the standard medical therapy, during
the first 48 hours after extubation, each patient received
three daily treatments by means of a lightweight, elastic
oronasal mask. Treatments (three sessions each) were
divided between morning, afternoon, and night, making
a total of nine daily sessions (one before extubation and
the others after extubation). No MI-E treatments were
performed after the study period.
The daily treatment frequency and its outcomes were
recorded in a diary by the nursing staff. All MI-E treat-
ments were administered by a trained respiratory thera-
pist, ICU physician, or nurse.
Criteria for reintubation
In both patient groups, the final decision to reintubate
was left to and made by the attending physician, who
recorded the single most relevant reason for reintuba-
tion. Reason to reintubate was the existence of at least
one of the following, as judged after the patient had
undergone the assigned treatment: (a) respiratory or car-
diac arrest; (b) respiratory pauses with loss of conscious-
ness; (c) respiratory distress despite 2-hour treatment
with SMT and NIV; (d) decreasing level of conscious-
ness; (c) intolerance to NIV; (f) hypotension, with a sys-
tolic blood pressure below 90 mm Hg for more than 30
minutes despite adequate volume challenge, the use of
vasopressors, or both; and (g) copious secretions that
could not be adequately cleared or that were associated
with severe hypoxemia. The final decision to reintubate
was made by the attending physician, who recorded the
single most relevant reason for reintubation. Only rein-
tubations required in the first 48 hours after extubation
were considered for this study.
Outcomes
Reintubation rate was considered the primary end point.
Total ICU length of stay, postextubation ICU length of
stay, and NIV failure rate were considered secondary
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end points. Reasons for reintubation were also analyzed
and compared between groups. A subgroup analysis,
both for primary and secondary end points, was per-
formed in patients that were submitted to postextuba-
tion NIV.
Statistical analysis
Descriptive data are reported as mean ± standard devia-
tion (SD). Statistical analysis was performed with SPSS
software (Release 15.0; SPSS, Chicago, I1, USA).
Sample-size calculation
After reviewing the reintubation rates of similar respira-
tory patients within our ICU and the most recent litera-
ture on this topic, a baseline reintubation rate of 60%
was estimated for this patient population. By using a
type 1 error of 5%, we estimated that we would need 33
patients in each group to have a power of 80% to detect
a reduction in reintubation rate to 30%. The latter was a
rate that was suggested as reasonable from the available
literature. In total, 75 patients were randomized. One
interim analysis was performed after inclusion of 50% of
the estimated patients by using an a curtailment (P <
0.005) to correct the analysis.
The primary end-point variable was to decrease rein-
tubation rates, defined by the necessity of mechanical
positive-pressure ventilation through orotracheal intuba-
tion in the first 48 hours after extubation, in the treat-
ment group.
Comparisons between groups
For all end points, differences between groups were ana-
lyzed by using an unpaired Student t test for the para-
metric variables and an unpaired Mann-Whitney test for
the nonparametric ones, respectively. P values were con-
sidered significant at < 0.05.
Results
In total, 92 patients were considered for the study per-
iod, 17 of whom did not meet the inclusion criteria.
Seventy-five patients (26 women) with a mean age of
61.8 ± 17.3 years old were randomized, 40 to the control
group (group A) and 35 to the study group (group B).
Baseline characteristics at baseline were similar in both
groups, as well as the reasons for MV. Demographic
data and patients’ characteristics at the entry into the
study are listed in Table 1.
During the 48 hours after extubation, none of the
patients from both groups died, and 19 (48%) from
group A and six (17%) from group B were reintubated.
Twenty patients (50%) from group A and 14 patients
(40%) from group B used NIV. All patients from both
groups for whom NIV failed, according to the criteria,
were reintubated. Considering this subgroup of patients,
the reintubation rates related to NIV failure were signifi-
cantly lower in the study group when compared with
controls; two patients (6%) versus 13 (33%); P < 0.05,
respectively.
Outcomes of both patient groups in the first 48 hours
after extubation, including the reintubation rates, causes
of reintubation, as well as ICU length of stay data, are
listed in Table 2. When compared with controls, both
duration of invasive mechanical ventilation and postex-
tubation ICU length of stay were significantly shorter by
6 days (P < 0.05), and the reintubation rate was signifi-
cantly lower (17% versus 48%) in the study group. No
significant differences were noted in total ICU length of
stay.
Discussion
The results found in this trial suggest that secretion
management with MI-E may work as a useful comple-
mentary technique to prevent reintubation in patients in
whom ARF develops in the first 48 hours after extuba-
tion. The use of MI-E had a stronger impact in prevent-
ing reintubation in the group of patients that required
NIV, as shown by the lower NIV failure rates in the
patients that were submitted to MI-E.
Significant debate still exists concerning the precise
indications and efficacy of NIV in this patient popula-
tion [30] without any mention of the problem of
impaired airway secretion.
The randomized controlled studies performed by Este-
ban et al. [20] and Keenan et al. [19] concluded that








Age (years) 62 ± 19.2 61.4 ± 15.1 NS
Sex (M/F) 21/19 28/7 NS
SAPS II 47.8 ± 17.7 45 ± 15 NS
Duration of MV (days) 9.4 ± 4.8 10.5 ± 4.1 NS
Patients with chronic pulmonary
disorders (n, %)
9 (23%) 7 (20%) NS
Patients with hypoxemic
respiratory failure (n,%)
24 (60%) 18 (52%) NS
Reasons for MV (n)
COPD exacerbations 6 4
Congestive heart failure 5 4
Community-acquired pneumonia 11 6
Hospital-acquired pneumonia - 2
Postoperative respiratory failure 5 8
Acute lung injury - 1
Thoracic trauma 6 3
Sepsis 7 4
Cardiac arrest - 3
Data are presented as mean ± standard deviation. COPD, chronic obstructive
pulmonary disease; MV, mechanical ventilation; NS, nonsignificant; SAPS II,
New Simplified Acute Physiology Score.
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NIV is not efficient in reducing reintubation rates, dura-
tion of invasive mechanical ventilation, and ICU and
hospital length of stay. None of these studies showed
improvement in survival in patients that used NIV in
addition to SMT. On the contrary, the trials conducted
by Nava et al. [31] and Ferrer et al. [32] showed that
NIV could prevent ARF after extubation. Several facts
may explain these differences.
First, whereas the studies by Keenan et al. [19] and
Esteban et al. [20] applied NIV after patients had devel-
oped symptoms of respiratory failure, the studies by
Nava et al. [31] and Ferrer et al. [32] previously identi-
fied the high-risk patients and applied NIV immediately
after extubation. As a longer time from extubation to
reintubation is associated with a worse outcome [33],
delay in reintubation correlates with worse survival rates
in patients who received NIV for established postextuba-
tion respiratory failure [19,20]. Thus, the early applica-
tion of NIV seems crucial to avoid respiratory failure
after extubation, and consequently reintubation.
Second, a significantly higher proportion of patients
with chronic respiratory disorders were included in the
studies that used early NIV in high-risk patients,
whereas the NIV postextubation respiratory-failure trials
enrolled only 10% to 11% of patients with chronic pul-
monary disease and used different definitions for postex-
tubation respiratory failure.
In our study, both study and control groups included
20% of patients with chronic respiratory disorders, and
all patients were closely monitored during the first 48
hours for early detection of signs and symptoms that
indicated postextubation respiratory failure. Similarly, in
the studies performed by Esteban et al. [20] and Keenan
et al. [19], NIV was applied only after the development
of those symptoms, according to specific criteria. How-
ever, in our study, NIV was applied in both groups
according to similar criteria, and only MI-E application
was considered an independent variable for group B
only.
Keenan et al. [19] showed a reintubation rate of 72%
and 69% in the study (submitted to NIV) and the con-
trol group, respectively. Esteban et al. [20] also showed
a high reintubation rate (48%) both in the study group
and in the control group. The patients enrolled in these
two studies were selected after confirmation of postextu-
bation respiratory failure, which may justify such higher
rates. Reintubation rates of the control group were also
relatively high in our study, and although we enrolled a
different population that underwent a planned extuba-
tion, this is a strong limitation of this study. However,
our patient population included only patients with acute
hypoxemic and/or hypercapnic respiratory failure with a
considerable risk of extubation failure, and we used the
same criteria for reintubation. Moreover, in our study,
NIV was used in both groups, and its failure rate was
also significant higher in group A (control group), a fact
that also may justify the high reintubation rate in this
group. The data in this study also confirm that extuba-
tion failure is associated with increased length of ICU
stay.
In our study, the main reason for reintubation in
group A was the presence of “secretion encumbrance
associated with severe hypoxemia,” in contrast with the
fact that only two patients from group B were reintu-
bated for the same reason. This fact may indicate that
secretion clearance with MI-E might have had a positive
role in preventing respiratory failure after extubation.
Secretion encumbrance with impaired airway clear-
ance has been considered an independent factor for
extubation failure [34], and associated with NIV failure
both in persistent weaning [18] and in postextubation
failure [20] patients. Although it is relatively easy to
manage secretions through an endotracheal tube, it can
be a serious problem after extubation and especially
during NIV. Deep-airway-suction suctioning through
the tube is a strategy most commonly used by nursing
staff to manage secretions; while patients are receiving






NIV application, n (%)
Reasons for NIV (n)
20 (50%) 14 (40%)
Respiratory rate > 35 beats/min 5 (25%) 9 (64%)
SpO2 < 90% 4 (20%) 1 (7%)
20% variation of HR or BP 1 (5%) -
PaO2 < 60; PaCO2 >45 10 (50%) 4 (29%)




Patients reintubated (n, %) 19 (48%)
a
6 (17%)a
Causes of reintubation (n)
Respiratory pauses with loss of consciousness - 1
Respiratory distress after 2-h NIV 6 2
Decreasing level of consciousness 2 -
Intolerance to NIV 2 -
Hypotension (systolic BP < 90 mm Hg for > 30
minutes)
- 1
Secretion encumbrance associated with severe
hypoxemia
9 2
NIV failure rate, n (%) 13 (65%)
a
2 (14%)a









Data are presented as mean ± standard deviation. APS II, New Simplified
Acute Physiology Score; COPD, chronic obstructive pulmonary disease; MV,
mechanical ventilation; NIV, noninvasive ventilation; NS, nonsignificant. aP <
0.05
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invasive MV, however, it can be traumatic, difficult to
perform, and often ineffective in the extubated patients,
because it must be performed blindly through the nose
or the mouth.
This study randomly used MI-E (CoughAssist; Phillips
Respironics International Inc., Murrysville, PA, USA)
before extubation via invasive tube and after extubation
through oronasal interface at sufficient inspiratory and
expiratory pressures (minimum of 40 to -40 cm H2O) to
expand fully and then to empty fully the adult lungs in
6 to 8 seconds, thereby expelling airway secretions while
avoiding both hyper- and hypoventilation. The ability to
use MI-E through the endotracheal tube immediately
before extubation was the main intervention that per-
mitted the study group patients to minimize the risk of
postextubation secretion encumbrance, and, together
with its three daily noninvasive applications, may have
had an influence on the reduction of reintubation and
NIV failure rates.
Although MI-E has been described as a very efficient
technique in the acute setting for patients with neuro-
muscular disease (NMD), in the treatment of respiratory
failure due to upper respiratory tract infections [28], to
avoid intubation [35], and to facilitate extubation,
decannulation, and to prevent postextubation failure
[36-38], the evidence supporting the role of this techni-
que in this other critically ill patient population is lack-
ing. Indeed, this study is the first randomized controlled
trial focused on MI-E in critical care.
The fact that strong evidence exists on the efficacy of
MI-E in critically ill patients with NMD, and the
authors’ positive experience with this technique in this
patient population, was the ethical reason to exclude
them from the study. Our group recently reported a
97% extubation success with full-setting noninvasive
ventilation (NIV) and MI-E in 157 NMD patients for
whom previous extubations and/or SBTs had failed [39].
Potential limitations must be taken into account when
analyzing the differences between the two groups. First,
although no significant differences in baseline character-
istics were found at the entry of the study between the
two groups, hypoxemic respiratory failure was slightly
more frequent in group A; this may had an impact on
the NIV failure rate and consequent higher reintubation
rate in this patient group, because NIV is more likely to
fail and reintubation be required when severe hypoxia is
present [40]. Second, six controls and four study group
patients were reintubated immediately with no indica-
tion for NIV. This fact was associated with causes that
could not be solved by MI-E, because cooperation with
the technique is crucial in extubated patients. Third,
ICU and hospital mortality was not analyzed, because
the study design was limited to the analysis of the out-
comes during the 48-hour postextubation period. This
fact limits the interpretation of the data concerning
long-term effects of MI-E in hospital mortality.
Another potential limitation of this type of open clini-
cal trial is the difficulty for a correct blinding of the
investigators that might lead to possible bias. Although
we predefined the criteria for all relevant interventions,
and clinical decisions to be made by the attending phy-
sicians, as well as the outcome variables, this bias could
not be entirely controlled.
Conclusions
Our results suggest that MI-E for secretion clearance is
safe and efficient in ICU respiratory patients with indi-
cations for mechanical ventilation, and we recommend
that this technique can be included proactively in an
extubation protocol only for specific subgroups of
patients that are candidates for a planned extubation,
but may be at risk of being reintubated for respiratory
failure after extubation. However, because of the paucity
of data, and the fact that this is a pilot study performed
in a center highly experienced with MI-E, more studies
are required to settle the issue in other critically ill
populations.
Key messages
• Secretion encumbrance is one of the main reasons
for respiratory failure after extubation.
• Mechanical insufflation-exsufflation (MI-E) is an
efficient technique for cough augmentation in ICU
respiratory patients, either through an endotracheal
tube or through a facial mask.
• Mechanical insufflation-exsufflation (MI-E) can be
efficient to manage copious secretions and help to
avoid reintubation, as well as to improve NIV effi-
cacy in patients that develop respiratory failure after
extubation.
• Successful extubation protocols, defined as reintu-
bation avoidance in the first 48 hours, have a posi-
tive impact in reducing postextubation ICU length
of stay in respiratory patients.
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